posted on 2011-10-13, 00:00authored byJoanna Romanowska, Michał Sobkowski, Agnieszka Szymańska-Michalak, Krystian Kołodziej, Aleksandra Dąbrowska, Andrzej Lipniacki, Andrzej Piasek, Zofia M. Pietrusiewicz, Marek Figlerowicz, Andrzej Guranowski, Jerzy Boryski, Jacek Stawiński, Adam Kraszewski
New synthetic protocol for the preparation of nucleoside 5′-(N-aryl)phosphoramidate monoesters 4 was developed. It consisted of a condensation of the corresponding nucleoside 5′-H-phosphonates with aromatic- or heteroaromatic amines promoted by diphenyl phosphorochloridate, followed by oxidation of the produced H-phosphonamidates with iodine/water. 5′-(N-Aryl)phosphoramidate monoesters derived from 3′-azido-3′-deoxythymidine (AZT) or 2′,3′-dideoxyuridine (ddU) nucleosides and various aromatic and heteroaromatic amines were evaluated as potential anti-HIV drugs. It was found that these compounds act most likely as pronucleotides and that some of them have therapeutic indices superior to those of the reference AZT.